Background: Anxiety in pregnancy is one of the strongest risk factors for postpartum depression (PPD), and high worry is a hallmark of many anxiety disorders. We sought to determine whether the Penn State Worry Questionnaire (PSWQ), designed for the general population, could identify high worry in pregnancy and predict the development of PPD symptoms (PPDS).
Methods: We followed women (N = 295) with and without mood and anxiety disorders across pregnancy and up to 6 months postpartum. Diagnoses were confirmed by SCID and by an experienced perinatal psychiatrist, and we administered the PSWQ and the Edinburgh Postnatal Depression Scale (EPDS) at up to 6 time points. We determined the trajectory of worry across time and its relationship to PPDS.
Results: Women with a history or current diagnosis of major depressive disorder (MDD) or generalized anxiety disorder (GAD) were more likely to experience high antenatal worry (defined as PSWQ >60), p < .004 for MDD and <0.001 for all others. High antenatal worry was the only significant predictor of PPDS, with an OR of 3.91 (95% CI 1.44-10.65); neither psychiatric diagnosis nor elevated antenatal depressive symptoms was significantly associated with PPDS in a multivariate model.
Limitations: Our study used self-report measures in a largely homogeneous population, which may limit the generalizability of our results.
Conclusions: The PSWQ may be a useful clinical tool in pregnancy. High worry is a strong predictor of PPDS, and is a better predictor of PPDS than psychiatric diagnosis or elevated antenatal depressive symptoms in this population.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442474 | PMC |
http://dx.doi.org/10.1016/j.jad.2021.07.009 | DOI Listing |
Background: The ability to accurately discern memory function (i.e., metamemory) decreases with age and is further diminished in Alzheimer's disease (AD).
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Roche Pharma AG, Grenzach-Wyhlen, Baden-Württemberg, Germany.
Background: The timely diagnosis of mild cognitive impairment (MCI) in Alzheimer's disease is challenging in routine care due to the complexity and time burden of required cognitive assessments. New unsupervised digital remote assessment tools could adress this challenge.
Method: The multicentric healthcare study "re.
Alzheimers Dement
December 2024
Brandeis University, Waltham, MA, USA.
Background: The ability to accurately discern memory function (i.e., metamemory) decreases with age and is further diminished in Alzheimer's disease (AD).
View Article and Find Full Text PDFAlzheimers Dement
December 2024
UMass Chan Medical School, Worcester, MA, USA.
Background: Almost all primary care providers (PCPs) believe screening for mild cognitive impairment (MCI) and dementia in older patients is important. However, there are significant barriers in primary care, including low provider confidence in their assessment skills, time constraints, competing priorities, and poor financial incentives. Consequently, PCPs report conducting cognitive assessments for less than half of patients over 60 years of age.
View Article and Find Full Text PDFNucleic Acids Res
January 2025
Laboratoire de Microbiologie et Génétique Moléculaires, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, 165 Rue Marianne Grunberg-Manago, 31400 Toulouse, France.
Antibiotic-resistant infections are a pressing clinical challenge. Plasmids are known to accelerate the emergence of resistance by facilitating horizontal gene transfer of antibiotic resistance genes between bacteria. We explore this question in Acinetobacter baumannii, a globally emerging nosocomial pathogen responsible for a wide range of infections with a worrying accumulation of resistance, particularly involving plasmids.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!